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A commentary on
Identification of a splicing variant that
regulates type 2 diabetes risk factor
CDKAL1 level by a coding-independent
mechanism in human
by Zhou, B., Wei, F. Y., Kanai, N., Fujimura,
A., Kaitsuka, T., and Tomizawa, K. (2014).
Hum. Mol. Genet. 23, 4639–4650. doi:
10.1093/hmg/ddu184
Since Richard J. Roberts and Phillip
A. Sharp discovered split genes (genes
are interrupted by RNA-encoding regions
called exons and non-coding segments
called introns in eukaryotic genome) in
1970’s, scientists have been finding many
genes can generate more than one mRNA
transcripts through AS (alternative splic-
ing, e.g., by different exon-exon combina-
tion). This AS strategy increases protein
repertoire, encodes proteins with diverse
and sometimes even antagonistic activities
(Kelemen et al., 2013). A new study led by
Dr. Kazuhito Tomizawa and first author Bo
Zhou from Kumamoto University in Japan
reports that CDKAL1-v1 (Cdk5 Regulator
Subunit Associated Protein 1-Like), one
splicing variant of CDKAL1, has no coding
ability but acts as a miRNA sponge RNA,
which regulates its full-length CDKAL1
protein (Zhou et al., 2014). Their results
give us a unique paradigm of how AS pos-
sesses a regulatory role in controlling gene
expression.
In addition to functioning as an “inter-
nal paralog” to deliver protein-coding
message (Modrek and Lee, 2003), the
main well-known mechanism of gene
regulation by AS is alternative splicing-
coupled nonsense-mediated decay (AS-
NMD). Briefly, Pre-mRNA alternative
splicing creates unstable mRNA isoforms
with PTC (premature termination codon).
Generally, if a PTC site is more than
∼50 nucleotides upstream of the last
exon-exon junction, this RNA isoform
will be degraded by NMD, an RNA
surveillance pathway to clean up splicing
errors which may lead to damaging trun-
cated proteins (Sibley, 2014). For exam-
ple, PTBP1 (polypyrimidine tract-binding
protein 1) is one typical splicing regu-
lator; it can regulate its own gene level
through PTBP1-dependent exon 11 skip-
ping to generate an AS-NMD transcript
(Wollerton et al., 2004). The auto regula-
tion through this negative-feedback loop
fine-tunes PTBP1 protein level in normal
FIGURE 1 | AS-NMD (A) and AS-ceRNAs (B) models of gene self-control. AS-NMD: alternative
splicing-coupled nonsense-mediated decay; AS-ceRNAs: alternative splicing-coupled competing
endogenous RNAs.
development (Figure 1A). Zhou et al.’s
study reveals a new mechanism where AS
can regulate its own gene via competition
for common miRNAs. Like regulation of
PTEN functional protein by crosstalk from
both pseudogene PTENP1, and cognate
genes by competing for common miR-
NAs of tumor suppressor PTEN (Poliseno
et al., 2010; Tay et al., 2011), AS offers a
simpler way to generate ceRNAs (com-
peting endogenous RNAs) by indirectly
regulating its own gene in this coding-
independent manner. Zhou et al. find
that although CDKAL1-v1 is a short splic-
ing variant which contains a PTC, it is
not subjected to NMD. Interestingly, this
non-coding RNA has the same targeting
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miRNA as full length CDKAL1, of which
is a type 2 diabetes risk factor associ-
ated with insulin secretion. By competing
miRNA bindings, CDKAL1-v1 RNA level
displays concordant expression pattern
with the full length CDKAL1 mRNA and
protein levels (Figure 1B). Small inter-
fering RNAs knockdown of CDKAL1-v1
markedly reduces the full CDKAL1 level or
vice versa. Their data suggest CDKAL1-v1-
mediated CDKAL1 gene may underlie type
2 diabetes pathogenesis. Here I term such
AS regulatory mechanism as alternative
splicing-coupled competing endogenous
RNAs (AS-ceRNAs) (Figure 1B).
CDKAL-v1 study by Zhou et al. (2014)
opens an intriguing new possibility, and
elucidates a critical but understudied layer
of AS role in gene control. Recent esti-
mate by next-generation RNA sequenc-
ing uncovers more than 90% multi-exon
human genes undergoing alternative splic-
ing (Pan et al., 2008; Wang et al., 2008),
but to answer how many of splicing vari-
ants are functional, not results of “aber-
rant splicing” or “noisy splicing,” is still
challenging. Post-transcriptional regula-
tion by AS-ceRNAs model will encour-
age us to reevaluate the regulatory role of
those uncharacterized splicing transcripts
in reciprocal interactions with their own
or cognate genes. RNA isoforms acting as
ceRNAs such as CDKAL1-v1 may become
splicing correcting targets for therapeutic
development.
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